Subthreshold Symptoms and Time to Relapse/recurrence in a Community Cohort of Bipolar Disorder Outpatients
Overview
Affiliations
Background: Researchers have previously found that persistent subthreshold symptoms increase the risk and shorten the time until an affective relapse in bipolar disorder (BD) patients. Research has mainly focused on patients from tertiary Care Centers in USA. We tested the hypothesis that even in a different setting, BD outpatients with subsyndromal affective symptoms would re.turn to a subsequent major affective episode significantly faster than completely asymptomatic at baseline. Secondarily, we analysed other variables related to time and risk to relapse.
Methods: A community cohort of BD outpatients from Madrid (Spain) followed-up in a systematic prospective follow-up protocol for up to five years were evaluated. Patients in clinical euthymia at baseline were included and evaluated quarterly.
Results: Initially, 225 patients were included in the survival analysis. Of them, according to predefined psychometric criteria, 163 were in euthymia (72.4%) and 62 (27.6%) suffered subsyndromal symptoms. Median follow-up was 157.6 weeks (95% CI, 78.14 to 111); 57.3% of patients experienced at least one affective episode during their follow-up. Median survival time to first affective episode was 109 weeks for patients in euthymia at baseline, versus 35 weeks for those with subsyndromal symptoms (p<0.0001). Psychosocial stress (p=0.003; HR 2.20; 95% CI 1.31-3.68) and the affective mood baseline state, subsyndromal vs. euthymic (p=0.046; HR 1.74; 95%CI 1.009-3.020), were related to time to first affective episode.
Limitations: Naturalistic study, some of the data collected were necessarily retrospective.
Conclusions: In Spanish non-tertiary psychiatric outpatients, subsyndromal BD symptoms and psychosocial stress at baseline predict earlier episode relapse/recurrence.
Rahimi Chahooei M, Zahedi Tajrishi K, Zargarinejad G, Shabani A BMC Psychiatry. 2025; 25(1):239.
PMID: 40082820 PMC: 11905722. DOI: 10.1186/s12888-025-06665-y.
Hett D, Morales-Munoz I, Durdurak B, Carlish M, Marwaha S Int J Bipolar Disord. 2023; 11(1):23.
PMID: 37391627 PMC: 10313572. DOI: 10.1186/s40345-023-00302-x.
KIOS: A smartphone app for self-monitoring for patients with bipolar disorder.
Pahwa M, McElroy S, Priesmeyer R, Siegel G, Siegel P, Nuss S Bipolar Disord. 2023; 26(1):84-92.
PMID: 37340215 PMC: 10730767. DOI: 10.1111/bdi.13362.
Zamar A, Kouimtsidis C, Lulsegged A, Roberts R, Koutsomitros T, Stahl D J Clin Med. 2022; 11(19).
PMID: 36233698 PMC: 9572106. DOI: 10.3390/jcm11195830.
Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder.
McInnis M, Andreassen O, Andreazza A, Alon U, Berk M, Brister T Bipolar Disord. 2022; 24(5):499-508.
PMID: 35244317 PMC: 9440950. DOI: 10.1111/bdi.13198.